ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 22, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	309	161	264	570	211	476
Market Cap Growth	3.39%	-39.20%	-53.63%	170.61%	-55.73%	-22.13%
Enterprise Value	226	56	187	430	145	406
Last Close Price	3.78	1.98	3.70	8.01	4.20	9.91
PE Ratio	-	-5.12	-3.85	-7.41	-3.69	-6.40
PS Ratio	18.20	22.05	56.74	210.75	167.32	219.30
PB Ratio	8.77	3.51	3.71	4.43	3.04	4.52
P/FCF Ratio	-3.50	7.21	-3.57	-18.91	-3.59	-9.52
P/OCF Ratio	-3.70	6.75	-3.61	-19.27	-3.66	-9.64
EV/Sales Ratio	13.39	7.63	40.19	158.93	115.23	187.34
EV/EBITDA Ratio	-1.55	-1.47	-2.72	-6.68	-2.45	-6.54
EV/EBIT Ratio	-1.50	-1.45	-2.69	-6.61	-2.33	-6.30
EV/FCF Ratio	-1.17	2.49	-2.53	-14.26	-2.47	-8.13
Debt / Equity Ratio	0.58	0.48	0.33	0.53	0.61	0.14
Debt / FCF Ratio	-0.53	0.98	-0.32	-2.28	-0.71	-0.30
Asset Turnover	0.12	0.04	0.02	0.02	0.01	0.02
Quick Ratio	2.70	3.51	7.24	6.83	7.44	10.29
Current Ratio	2.73	3.54	7.36	6.94	7.77	10.43
Return on Equity (ROE)	-50.39%	-51.33%	-71.37%	-71.62%	-62.00%	-60.85%
Return on Assets (ROA)	-13.28%	-14.06%	-21.38%	-23.20%	-29.36%	-31.53%
Return on Capital (ROIC)	-28.25%	-29.04%	-31.06%	-27.04%	-32.03%	-34.28%
Earnings Yield	-7.48%	-19.34%	-26.05%	-12.12%	-27.04%	-13.32%
FCF Yield	-12.65%	13.88%	-27.99%	-5.29%	-27.87%	-10.51%
Buyback Yield / Dilution	-6.47%	-13.08%	-11.62%	-28.21%	-21.99%	-20.51%
Total Shareholder Return	-6.47%	-13.08%	-11.62%	-28.21%	-21.99%	-20.51%

Source: S&P Capital IQ. Standard template. Financial Sources.